Mediware CEO George Barry To Step Down In October


LENEXA, Kan., May 16, 2005 (PRIMEZONE) -- Mediware Information Systems Inc.'s (Nasdaq:MEDW) chairman Lawrence A. Auriana announced that George "Bud" Barry will step down as chief executive officer, president and a director of the company in October 2005.

At the request of the board, Mr. Barry agreed to be available for consulting with management and the directors. He will also serve on the board's succession committee, chaired by Mr. Auriana. The committee includes two other board members, Phillip H. Coelho and Joseph DeLario.

Mr. Barry served as Mediware's chief financial officer in 1997 and 1998, and then rejoined the company as chief executive in January 2001 to manage a major restructuring, which was largely completed in early 2004. Mr. Barry has completed similar restructuring assignments at other high technology companies, where he was involved in more than 20 merger and acquisition transactions.

"Bud's earned the gratitude of the board and the entire organization for putting Mediware on a firm footing with strong growth potential. He's strengthened customer service, introduced new best of breed products in all divisions, and recruited a team of seasoned managers with deep industry experience and proven execution skills," Mr. Auriana said. "It's been a terrific four years and we look forward to building on the momentum he's created."

About Mediware

Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems. Its products include HCLL(tm) Transfusion, LifeTrak(r), IIE(tm) (Instrument Interface Engine), Hemocare(r), LifeLine(tm) (Blood Bank), WORx(r), MediCOE(tm), MediMAR(tm), Pharmakon(r), and Digimedics(tm) (Medication Management), Surgiware(tm) and Perioperative Solutions(tm) (Operating Room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom. Mediware has over 1,100 systems installed in the U.S., Canada, the U.K., and elsewhere.

Certain statements in this press release may constitute "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2004, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.



            

Mot-clé


Coordonnées